NO20035121D0 - New use - Google Patents

New use

Info

Publication number: NO20035121D0
Authority: NO; Norway
Prior art keywords: new use; new
Prior art date: 2001-05-18

Application number

NO20035121A

Other languages

Norwegian (no)

Other versions

NO20035121L (en

Inventor

Douglas William Pierre Hay

Gareth John Sanger

Yadataka Yamada

Original Assignee

Smithkline Beecham Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-18

Filing date

2003-11-17

Publication date

2003-11-17

2001-05-18 Priority claimed from GB0112208A external-priority patent/GB0112208D0/en

2001-12-06 Priority claimed from GB0129268A external-priority patent/GB0129268D0/en

2003-11-17 Application filed by Smithkline Beecham Co filed Critical Smithkline Beecham Co

2003-11-17 Publication of NO20035121D0 publication Critical patent/NO20035121D0/en

2003-11-17 Publication of NO20035121L publication Critical patent/NO20035121L/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

NO20035121A 2001-05-18 2003-11-17 New use NO20035121L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0112208A GB0112208D0 (en)	2001-05-18	2001-05-18	New use
GB0129268A GB0129268D0 (en)	2001-12-06	2001-12-06	Novel use
PCT/US2002/015911 WO2002094187A2 (en)	2001-05-18	2002-05-17	Novel use

Publications (2)

Publication Number	Publication Date
NO20035121D0 true NO20035121D0 (en)	2003-11-17
NO20035121L NO20035121L (en)	2003-11-17

Family

ID=26246093

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035121A NO20035121L (en)	2001-05-18	2003-11-17	New use

Country Status (19)

Country	Link
EP (1)	EP1387687A4 (en)
JP (1)	JP2004534761A (en)
KR (1)	KR20040016865A (en)
CN (1)	CN1269483C (en)
AR (1)	AR045879A1 (en)
AU (1)	AU2002303811B2 (en)
BR (1)	BR0209662A (en)
CA (1)	CA2447063A1 (en)
CZ (1)	CZ20033115A3 (en)
HU (1)	HUP0400966A2 (en)
IL (1)	IL158701A0 (en)
MX (1)	MXPA03010509A (en)
MY (1)	MY134211A (en)
NO (1)	NO20035121L (en)
NZ (1)	NZ529462A (en)
PE (1)	PE20021067A1 (en)
PL (1)	PL367308A1 (en)
TW (1)	TWI243678B (en)
WO (1)	WO2002094187A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
EP1911763B1 (en)	2003-01-28	2010-08-11	Ironwood Pharmaceuticals, Inc.	Compositions for the treatment of gastrointestinal disorders
AU2005231355B2 (en) *	2004-03-30	2008-09-18	Smithkline Beecham Corporation	Spray dried pharmaceutical compositions
WO2005100997A2 (en) *	2004-04-16	2005-10-27	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with tachykinin receptor 3 (tacr3)
JP2009510121A (en) *	2005-09-30	2009-03-12	スミスクライン・ビーチャム・コーポレイション	Pharmaceutical composition
TW200804288A (en)	2005-12-12	2008-01-16	Astrazeneca Ab	Alkylsulphonamide quinolines
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (en)	2007-06-04	2018-03-21	Synergy Pharmaceuticals Inc	AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
ES2522968T3 (en)	2008-06-04	2014-11-19	Synergy Pharmaceuticals Inc.	Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en)	2008-07-16	2015-02-19	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
MX381407B (en)	2008-12-31	2025-03-12	Ardelyx Inc	COMPOUNDS AND METHODS FOR INHIBITING SODIUM ION/HYDROGEN ION EXCHANGER (NHE)-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND DISORDERS OF THE GASTROINTESTINAL TRACT.
WO2018129556A1 (en)	2017-01-09	2018-07-12	Ardelyx, Inc.	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR200452372Y1 (en) *	2010-05-14	2011-02-22	서일수	Communication line support device of construction lift
KR101034774B1 (en) *	2010-07-30	2011-05-17	(주)챔피온코리아	Lift device using wire rope
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
MX366293B (en)	2012-08-21	2019-07-04	Ardelyx Inc	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders.
US10376481B2 (en)	2012-08-21	2019-08-13	Ardelyx, Inc.	Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
HRP20191000T1 (en)	2013-04-12	2019-09-20	Ardelyx, Inc.	Nhe3-binding compounds and methods for inhibiting phosphate transport
WO2014170648A1 (en)	2013-04-19	2014-10-23	Astrazeneca Ab	A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos)
BR112015030326A2 (en)	2013-06-05	2017-08-29	Synergy Pharmaceuticals Inc	ULTRAPURE GUANYLATE CYCLASE C AGONISTS, METHOD OF MANUFACTURING AND USING THEM
MX2019008171A (en)	2017-01-09	2020-02-05	Ardelyx Inc	Inhibitors of nhe-mediated antiport.
MX395405B (en)	2017-01-09	2025-03-25	Ardelyx Inc	COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2719311B1 (en) *	1994-03-18	1998-06-26	Sanofi Sa	Compounds that are selective antagonists of the human NK3 receptor and their use as drugs and diagnostic tools.
US5434158A (en) *	1994-04-26	1995-07-18	Merck & Co., Inc.	Spiro-substituted azacycles as neurokinin-3 antagonists
AR004735A1 (en) *	1995-11-24	1999-03-10	Smithkline Beecham Spa	CHINOLEIN 4-AMIDO SUBSTITUTED, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
EP0983262B1 (en) *	1997-05-23	2003-07-09	GlaxoSmithKline S.p.A.	Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
JP2002530377A (en) *	1998-11-20	2002-09-17	スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ	Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists

2002
- 2002-05-16 MY MYPI20021787A patent/MY134211A/en unknown
- 2002-05-17 KR KR10-2003-7014960A patent/KR20040016865A/en not_active Withdrawn
- 2002-05-17 MX MXPA03010509A patent/MXPA03010509A/en not_active Application Discontinuation
- 2002-05-17 CZ CZ20033115A patent/CZ20033115A3/en unknown
- 2002-05-17 PL PL02367308A patent/PL367308A1/en not_active Application Discontinuation
- 2002-05-17 WO PCT/US2002/015911 patent/WO2002094187A2/en not_active Ceased
- 2002-05-17 HU HU0400966A patent/HUP0400966A2/en unknown
- 2002-05-17 NZ NZ529462A patent/NZ529462A/en unknown
- 2002-05-17 PE PE2002000415A patent/PE20021067A1/en not_active Application Discontinuation
- 2002-05-17 CN CNB028101588A patent/CN1269483C/en not_active Expired - Fee Related
- 2002-05-17 AU AU2002303811A patent/AU2002303811B2/en not_active Ceased
- 2002-05-17 JP JP2002590908A patent/JP2004534761A/en active Pending
- 2002-05-17 EP EP02731870A patent/EP1387687A4/en not_active Withdrawn
- 2002-05-17 CA CA002447063A patent/CA2447063A1/en not_active Abandoned
- 2002-05-17 BR BR0209662-5A patent/BR0209662A/en not_active IP Right Cessation
- 2002-05-17 TW TW091110318A patent/TWI243678B/en active
- 2002-05-17 IL IL15870102A patent/IL158701A0/en unknown
- 2002-05-17 AR ARP020101845A patent/AR045879A1/en not_active Application Discontinuation
2003
- 2003-11-17 NO NO20035121A patent/NO20035121L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20040016865A (en)	2004-02-25
CZ20033115A3 (en)	2004-09-15
WO2002094187A3 (en)	2003-05-30
EP1387687A2 (en)	2004-02-11
IL158701A0 (en)	2004-05-12
WO2002094187A2 (en)	2002-11-28
PL367308A1 (en)	2005-02-21
JP2004534761A (en)	2004-11-18
AU2002303811B2 (en)	2005-07-07
CN1509175A (en)	2004-06-30
PE20021067A1 (en)	2003-02-02
MXPA03010509A (en)	2004-03-02
NZ529462A (en)	2005-07-29
MY134211A (en)	2007-11-30
HUP0400966A2 (en)	2004-08-30
EP1387687A4 (en)	2006-07-05
TWI243678B (en)	2005-11-21
BR0209662A (en)	2004-04-20
NO20035121L (en)	2003-11-17
CA2447063A1 (en)	2002-11-28
CN1269483C (en)	2006-08-16
AR045879A1 (en)	2005-11-16

Legal Events

Date	Code	Title	Description
2008-01-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20023616L (en)	2002-09-17	New use
IS7016A (en)	2003-11-05	New 4-anilinoquinoline-3-carboxamide
ATE524462T1 (en)	2011-09-15	C5-MODIFIED INDAZOLYLPYRROLOTRIAZINES
NO20035121D0 (en)	2003-11-17	New use
ATE335486T1 (en)	2006-09-15	HYDRAZONO-MALONITRILE
ATE355059T1 (en)	2006-03-15	ISOXAZOLOPYRIDINONES
NO20034649D0 (en)	2003-10-17	Tilstrammingsanordning
ATA18372001A (en)	2005-07-15	GELENKSBOLZENBAUEINHEIT
NO20033919L (en)	2003-09-04	New use
ATE319694T1 (en)	2006-03-15	PHENYLALKYNE
ATA13992002A (en)	2003-10-15	SCHLACKENGRANULIERUNGSANLAGE
DE10295006D2 (en)	2004-10-07	Bauwerksabdichtung
DE50108381D1 (en)	2006-01-19	Synchronisierschaltungsanordnung
ATE345337T1 (en)	2006-12-15	DELTA1 -PYRROLINES
ATA7462001A (en)	2002-01-15	Radspannwerk
SE0104092D0 (en)	2001-12-03	New use
SE0102574D0 (en)	2001-07-20	New Use
SE0103291D0 (en)	2001-10-03	New use
SE0101160D0 (en)	2001-03-30	New use
SE0100798D0 (en)	2001-03-08	New use
SE0103540D0 (en)	2001-10-23	New Use
SE0103767D0 (en)	2001-11-09	New use
SE0103768D0 (en)	2001-11-09	New use
SE0104065D0 (en)	2001-12-04	New use
SE0100062D0 (en)	2001-01-10	New use